Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Graph Frequency Bands and Functional Connectivity-based Features.

Basic and clinical neuroscience·2026
Same author

Multivariate patterns of plasma biomarkers predict region-specific Alzheimer's pathology and cognitive decline across independent cohorts.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Predicting future amyloid conversion: the role of baseline amyloid distribution, genetic and cognitive resilience.

NPJ dementia·2025
Same author

Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Investigating the role of auditory cues in modulating motor timing: insights from EEG and deep learning.

Cerebral cortex (New York, N.Y. : 1991)·2024
Same author

Structural filtering of functional data offered discriminative features for autism spectrum disorder.

PloS one·2022

Related Experiment Video

Updated: Jun 22, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Graph Frequency Bands and

Jafar Zamani1, Alireza Talesh Jafadideh2

  • 1Department of Psychiatry and Behavioral Sciences, Stanford University, California, USA.

Research Square
|July 1, 2024
PubMed
Summary

Predicting Alzheimer's disease progression from mild cognitive impairment is vital. Machine learning models using resting-state fMRI data can identify individuals at risk, aiding early diagnosis and intervention strategies.

Keywords:
Alzheimer’s diseaseMild cognitive impairmentclassificationconnectivity-based featuresgraph signal processing

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Related Experiment Videos

Last Updated: Jun 22, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Computational Biology

Background:

  • Accurate prediction of mild cognitive impairment (MCI) progression to Alzheimer's disease (AD) is critical for effective patient management.
  • Machine learning (ML) and resting-state functional magnetic resonance imaging (rs-fMRI) show promise in classifying AD and MCI.
  • Identifying individuals with progressive MCI (pMCI) versus stable MCI (sMCI) is key for timely interventions.

Purpose of the Study:

  • To develop and validate an ML-based framework for predicting MCI to AD progression using rs-fMRI data.
  • To identify a parsimonious set of connectivity-based features for accurate classification.
  • To enhance the precision of early AD risk assessment.

Main Methods:

  • Utilized three years of rs-fMRI data from 142 sMCI and 136 pMCI patients in the ADNI cohort.
  • Applied graph signal processing to filter rs-fMRI data into low, middle, and high frequency bands.
  • Extracted connectivity-based features, performed feature selection using particle swarm optimization (PSO) and simulated annealing (SA), and classified using support vector machine (SVM) with radial basis function (RBF) kernel and 10-fold cross-validation.

Main Results:

  • The proposed framework achieved optimal accuracy with minimal feature utilization.
  • Using PSO-selected features, the SVM model demonstrated 77% accuracy, 70% specificity, and 83% sensitivity.
  • Key predictive features included graph metrics (clustering coefficient, strength, eccentricity, modularity) across different frequency bands.

Conclusions:

  • The study highlights the efficacy of the proposed framework in identifying individuals at risk of AD development.
  • A parsimonious feature set derived from filtered rs-fMRI data can accurately predict MCI to AD progression.
  • This approach offers a promising tool for advancing precision in early AD diagnosis and intervention.